Parkinson disease

被引:0
|
作者
Keller, David L. [1 ]
机构
[1] Providence Med Inst, Torrance, CA USA
关键词
RISK;
D O I
10.3949/ccjm.79c:04006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:242 / 243
页数:2
相关论文
共 50 条
  • [21] Parkinson Disease
    Vaubel, Rachael A.
    Raghunathan, Aditya
    Erickson, Lori A.
    MAYO CLINIC PROCEEDINGS, 2016, 91 (11) : E155 - E156
  • [23] PARKINSON DISEASE
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1948, 1 (4561): : 1119 - 1120
  • [24] ON PARKINSON DISEASE
    SCHWAB, RS
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1959, 84 (34) : 1485 - 1489
  • [25] The Parkinson disease before James Parkinson
    Francesco Raudino
    Neurological Sciences, 2012, 33 : 945 - 948
  • [26] The Parkinson disease before James Parkinson
    Raudino, Francesco
    NEUROLOGICAL SCIENCES, 2012, 33 (04) : 945 - 948
  • [27] PARKINSON DISEASE Progress towards a molecular biomarker for Parkinson disease
    Foulds, Penelope
    Mann, David M. A.
    Mitchell, J. Douglas
    Allsop, David
    NATURE REVIEWS NEUROLOGY, 2010, 6 (07) : 359 - 361
  • [28] PARKINSON DISEASE Another player in gene therapy for Parkinson disease
    Kaplitt, Michael G.
    NATURE REVIEWS NEUROLOGY, 2010, 6 (01) : 7 - 8
  • [29] PARKINSON DISEASE How reliable are prodromal indicators of Parkinson disease?
    Silveira-Moriyama, Laura
    Lees, Andrew J.
    NATURE REVIEWS NEUROLOGY, 2015, 11 (01) : 5 - U6666
  • [30] Parkinson's Disease 2 The pathogenesis of Parkinson's disease
    Morris, Huw R.
    Spillantini, Maria Grazia
    Sue, Carolyn M.
    Williams-Gray, Caroline H.
    LANCET, 2024, 403 (10423): : 293 - 304